Skip to content

Based on fNIRS Technology: The Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Cognitive Function After Stroke

Based on fNIRS Technology: The Effects of Transcutaneous Auricular Vagus Nerve Stimulation on Cognitive Function After Stroke

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097192
Enrollment
Unknown
Registered
2025-02-14
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive impairment after stroke can result in impaired cognitive functions such as memory, attention, execution, comprehension, and judgment, seriously affecting the patient's daily life and social activities, and hindering comprehensive recovery after stroke

Interventions

Test group:Conventional rehabilitation therapy+Transcutaneous vagus nerve electrical stimulation (ear nail area)
Control group:Conventional rehabilitation therapy+Transcutaneous vagus nerve electrical stimulation (in the ear area)

Sponsors

Yuebei People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Patients confirmed by CT or MRI as having a stroke; 2.Meets the diagnostic criteria for PSCIND, with MoCA score<26 and MMSE score = 21; 3.Stable condition, able to cooperate in completing fNIRS testing; 4.First onset, course of illness between 2 weeks and 6 months; 5.Individuals aged 40-85; 6.Having received at least 6 years of education; 7.Not receiving non-invasive neuromodulation therapy for the brain in the past 3 months;

Exclusion criteria

Exclusion criteria: 1.Individuals with consciousness disorders, severe visual, hearing, and language impairments, as well as other health assessments that cannot be completed; 2.There are other types of brain diseases (multiple sclerosis, brain tumors, etc.); 3.Cognitive impairment caused by other reasons, such as Alzheimer's disease (AD), Lewy body dementia, etc; 4.Patients after intracranial implantation of metal, electronic devices, and metal skull repair surgery; 5.Patients with contraindications to vagus nerve electrical stimulation (such as atrial fibrillation); 6.Patients who have had their ears removed, causing the stimulation device to be unable to be placed; 7.Combining tumors, severe systemic diseases such as heart and lung diseases; 8.Pregnant, breastfeeding, or planning to conceive; 9.Due to other reasons, the subjects were unable to tolerate the test during the trial process; 10.Patients and their families who are unwilling to sign informed consent forms;

Design outcomes

Primary

MeasureTime frame
fNIRS;MoCA;

Secondary

MeasureTime frame
MMSE;MBI;

Countries

China

Contacts

Public ContactLiu Tingting

Yuebei People’s Hospital

563876302@qq.com+86 751 691 3354

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026